What are Avanos Medical's total assets?

Avanos Medical (AVNS) holds $1.1B in total assets, down 5.2% year over year.

How much debt does Avanos Medical have?

Avanos Medical carries $138.4M in total debt against $782.1M of shareholders' equity, a debt-to-equity ratio of 0.18.

How much cash does Avanos Medical have?

Avanos Medical holds $65.6M in cash and equivalents.

Can Avanos Medical cover its short-term obligations?

Its current ratio is 2.48 — current assets exceed current liabilities.

Where does Avanos Medical's balance sheet data come from?

Every line is extracted from Avanos Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Avanos Medical AVNS Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$65.6M-26.9%	$89.8M+27.4%	$70.5M-21.9%	$90.3M-6.9%	$97M-9.9%
Accounts receivable, net	$103M-0.8%	$103.8M-6.9%	$111.5M+1.2%	$110.2M+5.2%	$104.8M-21.1%
Inventories	$141.3M-4.5%	$148M-1.7%	$150.6M+5.5%	$142.7M+3.3%	$138.1M-0.5%
Raw materials	$34.1M-1.7%	$34.7M-6.5%	$37.1M+1.1%	$36.7M-1.9%	$37.4M+2.5%
Work in process	$25M-0.8%	$25.2M-14.0%	$29.3M+2.8%	$28.5M+25.6%	$22.7M+7.6%
Finished goods	$78.2M-6.9%	$84M+4.7%	$80.2M+7.9%	$74.3M-0.7%	$74.8M-4.5%
Prepaid expenses and other current assets	$15.1M+9.4%	$13.8M-26.6%	$18.8M+46.9%	$12.8M+2.4%	$12.5M-11.3%
Income taxes receivable	$100K0.0%	$100K-50.0%	$200K0.0%	$200K-50.0%	$400K-91.8%
Materials and supplies	$4M-2.4%	$4.1M+2.5%	$4M+25.0%	$3.2M0.0%	$3.2M+10.3%
Total current assets	$325M-8.6%	$355.4M+1.1%	$351.4M-1.3%	$356M+1.0%	$352.4M-10.4%
Property and equipment, net	$111.2M-1.9%	$113.4M-1.7%	$115.4M+1.0%	$114.3M+4.1%	$109.8M-0.8%
Accumulated depreciation	$157.3M+3.4%	$152.1M-1.2%	$154M+5.1%	$146.5M+4.3%	$140.5M+1.3%
Operating lease right-of-use assets	$39.3M+42.4%	$27.6M-7.7%	$29.9M-3.9%	$31.1M-3.1%	$32.1M-5.9%
Goodwill	$394M-0.2%	$394.9M+0.1%	$394.4M+3.5%	$381.2M-16.4%	$455.9M+0.1%
Intangible assets, net	$114.7M-2.6%	$117.8M-3.4%	$122M+15.7%	$105.4M-1.7%	$107.2M-4.5%
Other non-current assets	$32.9M+4.4%	$31.5M+7.5%	$29.3M+14.0%	$25.7M+1.2%	$25.4M+9.5%
Total assets	$1.05B-2.2%	$1.07B+0.6%	$1.07B+2.8%	$1.04B-6.2%	$1.11B-4.0%
Accounts payable	$52.3M-5.8%	$55.5M+2.4%	$54.2M+11.1%	$48.8M+6.1%	$46M-15.3%
Accrued expenses	$57.6M-36.9%	$91.3M+22.1%	$74.8M+13.3%	$66M-7.6%	$71.4M-21.8%
Accrued compensation	$21.7M-41.4%	$37M+12.1%	$33M+38.1%	$23.9M+21.3%	$19.7M-38.6%
Current portion of long-term debt	$10.9M+6.9%	$10.2M+8.5%	$9.4M0.0%	$9.4M0.0%	$9.4M0.0%
Operating lease liabilities, current	$10.4M+26.8%	$8.2M-13.7%	$9.5M-8.7%	$10.4M0.0%	$10.4M-4.6%
Income taxes payable	$6.6M-60.9%	$16.9M+252%	$4.8M-12.7%	$5.5M-66.7%	$16.5M-8.3%
Total current liabilities	$131.2M-20.6%	$165.2M+11.7%	$147.9M+9.9%	$134.6M-1.9%	$137.2M-17.3%
Long-term debt	$87.3M-3.3%	$90.3M-3.3%	$93.4M-2.4%	$95.7M-2.3%	$98M-21.8%
Operating lease liabilities, non-current	$29.8M+46.1%	$20.4M-4.7%	$21.4M-1.8%	$21.8M-5.6%	$23.1M-6.1%
Other non-current liabilities	$14.1M+4.4%	$13.5M-34.8%	$20.7M+381%	$4.3M-4.4%	$4.5M+2.3%
Total liabilities	$268M-9.3%	$295.5M+2.0%	$289.7M+10.3%	$262.7M-2.1%	$268.4M-17.6%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	300M0.0%	300M0.0%	300M0.0%	300M0.0%	300M+59,900%
Additional paid-in capital	$1.7B+0.2%	$1.69B+0.1%	$1.69B+0.2%	$1.69B+0.2%	$1.68B+0.3%
Retained earnings	-$774.8M+0.7%	-$779.9M-0.2%	-$778.6M-0.2%	-$777.2M-11.0%	-$700.4M+0.9%
Accumulated other comprehensive income (loss)	-$36M-12.5%	-$32M+1.8%	-$32.6M-1.9%	-$32M+24.3%	-$42.3M+5.2%
Treasury stock	$103.6M+1.3%	$102.3M+0.3%	$102M+0.1%	$101.9M+0.7%	$101.2M+2.2%
Total stockholders' equity	$782.1M+0.5%	$778.2M0.0%	$778M+0.2%	$776.3M-7.5%	$839.4M+1.3%
Total liabilities and stockholders' equity	$1.05B-2.2%	$1.07B+0.6%	$1.07B+2.8%	$1.04B-6.2%	$1.11B-4.0%
Deferred Tax Assets and Other Non-Current Assets	$32.9M+4.4%	$31.5M+7.5%	$29.3M+14.0%	$25.7M+1.2%	$25.4M+9.5%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Finite Lived Intangible Assets - Gross	$389.2M+0.3%	$387.9M+0.1%	$387.6M+4.4%	$371.3M+1.0%	$367.8M+0.1%
Net Investment in Lease	$39.3M+42.4%	$27.6M-7.7%	$29.9M-3.9%	$31.1M-3.1%	$32.1M-5.9%
Deferred tax assets	$33M-0.3%	$33.1M+30.8%	$25.3M0.0%	$25.3M+1.2%	$25M+0.4%
Intangible assets — net	$114.7M-2.6%	$117.8M—	——	——	——
Other intangible assets—net	$114.7M-2.6%	$117.8M-3.4%	$122M+15.7%	$105.4M-1.7%	$107.2M-4.5%
Operating lease right-of-use assets	$39.3M+42.4%	$27.6M-7.7%	$29.9M-3.9%	$31.1M-3.1%	$32.1M-5.9%
Other non-current assets	$32.9M+4.4%	$31.5M+7.5%	$29.3M+14.0%	$25.7M+1.2%	$25.4M+9.5%
Property, plant and equipment at cost	$268.5M+1.1%	$265.5M-1.4%	$269.4M+3.3%	$260.8M+4.2%	$250.3M+0.4%
Operating Lease Right-of-Use Assets in Other Assets	$39.3M+42.4%	$27.6M-7.7%	$29.9M-3.9%	$31.1M-3.1%	$32.1M-5.9%
Software and Technology Licenses, Net	$32.9M+4.4%	$31.5M+7.5%	$29.3M+14.0%	$25.7M+1.2%	$25.4M+9.5%
Other Commercial Liabilities	$57.6M-36.9%	$91.3M+22.1%	$74.8M+13.3%	$66M-7.6%	$71.4M-21.8%
Accrued Liabilities, Current	$57.6M-36.9%	$91.3M+22.1%	$74.8M+13.3%	$66M-7.6%	$71.4M-21.8%
Contingent Consideration Liability (Non-Current)	——	——	——	——	——
Debt Maturity - 2024	——	——	——	——	——
Debt Maturity - 2027	——	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$200K-33.3%	$300K0.0%	$300K-25.0%	$400K0.0%	$400K-20.0%
Total debt	$138.4M+7.2%	$129.1M-3.4%	$133.7M-2.6%	$137.3M-2.6%	$140.9M-17.2%
Total Carrying Value of Debt	$98.4M-2.4%	$100.8M-2.2%	$103.1M-2.3%	$105.5M-2.1%	$107.8M-20.3%
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Convertible Preferred Stock Authorized Shares	20M0.0%	20M0.0%	20M0.0%	20M0.0%	20M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$500K0.0%	$500K0.0%	$500K0.0%	$500K0.0%	$500K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Cumulative Cost Basis	$268.5M+1.1%	$265.5M-1.4%	$269.4M+3.3%	$260.8M+4.2%	$250.3M+0.4%
Accounts Receivable, after Allowance for Credit Loss	$103M-0.8%	$103.8M-6.9%	$111.5M+1.2%	$110.2M+5.2%	$104.8M-21.1%
Accrued compensation and benefits	$4.1M+2.5%	$4M-4.8%	$4.2M+2.4%	$4.1M-4.7%	$4.3M+2.4%
Accrued customer incentives	$10M+2.0%	$9.8M-10.9%	$11M+10.0%	$10M-1.0%	$10.1M-7.3%
Accrued rebates	$1M-69.7%	$3.3M-54.8%	$7.3M-44.3%	$13.1M+9.2%	$12M-9.8%
Accrued rebates and customer incentives	$11M-16.0%	$13.1M-28.4%	$18.3M-20.8%	$23.1M+4.5%	$22.1M-8.7%
Accrued Rebates And Incentives	$11M-16.0%	$13.1M-28.4%	$18.3M-20.8%	$23.1M+4.5%	$22.1M-8.7%
Accrued Sales Returns	-$100K0.0%	-$100K0.0%	-$100K0.0%	-$100K0.0%	-$100K0.0%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$300M0.0%	$300M0.0%	$300M0.0%	$300M0.0%	$300M0.0%
Common Stock, Shares, Outstanding	$46.67M+0.5%	$46.46M+0.1%	$46.42M+0.2%	$46.31M+0.2%	$46.24M+0.6%
Long-term debt, gross	$98.4M-2.4%	$100.8M-2.2%	$103.1M-2.3%	$105.5M-2.1%	$107.8M-20.3%
Less: net unamortized discount	$200K-33.3%	$300K0.0%	$300K-25.0%	$400K0.0%	$400K-20.0%
Deferred income taxes	$5.6M-8.2%	$6.1M-3.2%	$6.3M0.0%	$6.3M+12.5%	$5.6M+1.8%
Thereafter	——	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$274.5M+1.6%	$270.1M+1.7%	$265.6M+60.3%	$165.7M+3.3%	$160.4M+3.5%
2028	——	——	——	——	——
2030	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Gross Carrying Amount	$389.2M+0.3%	$387.9M+0.1%	$387.6M+4.4%	$371.3M+1.0%	$367.8M+0.1%
Income taxes receivable	$100K0.0%	$100K-50.0%	$200K0.0%	$200K-50.0%	$400K-91.8%
Raw materials	$34.1M-1.7%	$34.7M-6.5%	$37.1M+1.1%	$36.7M-1.9%	$37.4M+2.5%
Liabilities For Estimated Rebates And Incentives, Net	$11.1M-15.9%	$13.2M-28.3%	$18.4M-20.7%	$23.2M+4.5%	$22.2M-8.6%
2028	——	——	——	——	——
2029	——	——	——	——	——
2030	——	——	——	——	——
2027	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
Other accrued liabilities	$18.3M-24.7%	$24.3M+29.9%	$18.7M+38.5%	$13.5M+3.1%	$13.1M-22.9%
Other	$10M+5.3%	$9.5M-42.4%	$16.5M+8,150%	$200K0.0%	$200K0.0%
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Remainder of Fiscal Year 2024	——	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Avanos Medical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Avanos Medical's total assets?: Avanos Medical (AVNS) holds $1.1B in total assets, down 5.2% year over year.
How much debt does Avanos Medical have?: Avanos Medical carries $138.4M in total debt against $782.1M of shareholders' equity, a debt-to-equity ratio of 0.18.
How much cash does Avanos Medical have?: Avanos Medical holds $65.6M in cash and equivalents.
Can Avanos Medical cover its short-term obligations?: Its current ratio is 2.48 — current assets exceed current liabilities.
Where does Avanos Medical's balance sheet data come from?: Every line is extracted from Avanos Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.